title: [Medical treatment of patients with primary hyperparathyroidism].
abstract: Surgery is the recommended treatment for primary hyperparathyroidism. For exceptional medical treatment, the main drugs available are cinacalcet to normalize plasma calcium, and bisphosphonates to prevent bone loss. The patients eligible for medical therapy are those who cannot be operated or whose condition persists despite optimal surgical treatment. However, PHPT can cause other complications that need special attention regarding prevention and treatment during follow-up.
authors.affiliation: Osteoporoseklinikken, Arhus Universitetshospital, Arhus Sygehus THG, DK-8000 Arhus C. p-vest@post4.tele.dk
authors.forename: Peter
authors.initials: P
authors.lastname: Vestergaard
authors.forename: Leif
authors.initials: L
authors.lastname: Mosekilde
mesh_terms: D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D002118:Calcium / Q000097:blood; D000069449:Cinacalcet; D004164:Diphosphonates / Q000627:therapeutic use; D006801:Humans; D049950:Hyperparathyroidism, Primary / Q000097:blood / Q000188:drug therapy*; D009281:Naphthalenes / Q000627:therapeutic use
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D009281:Naphthalenes; D002118:Calcium; D000069449:Cinacalcet